CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO
|
EQS-Ad-hoc: CompuGroup Medical SE & Co. KGaA / Key word(s): Personnel CompuGroup Medical SE & Co. KGaA appoints Prof. Dr. Daniel Gotthardt as new CEO Koblenz, Germany. The general partner of CompuGroup Medical SE & Co. KGaA (the “Company”) (ISIN: DE000A288904 | WKN: A28890) announces that the Administrative Board of CompuGroup Medical Management SE and CEO Michael Rauch decided today in mutual agreement to terminate his contract prematurely as of August 31, 2024, including resignation from his position as Managing Director and member of the Administrative Board of CompuGroup Medical Management SE as well as of the Joint Committee of the Company. Effective as of September 1, 2024, the Administrative Board of CompuGroup Medical Management SE appoints Prof. (apl.) Dr. med. Daniel Gotthardt as Managing Director and CEO. Daniel Gotthardt has been Senior Vice President and Chief Medical Officer of the Company since the beginning of 2023. He has also been a member of the Supervisory Board of former CompuGROUP Holding AG and CompuGroup Medical SE since 2003, and has been a member of the Administrative Board of CompuGroup Medical Management SE since 2020.
End of Inside Information
31-Jul-2024 CET/CEST The EQS Distribution Services include Regulatory Announcements, Financial/Corporate News and Press Releases. |
| Language: | English |
| Company: | CompuGroup Medical SE & Co. KGaA |
| Maria Trost 21 | |
| 56070 Koblenz | |
| Germany | |
| Phone: | +49 (0)160 3630362 |
| Fax: | +49 (0)261 8000 3200 |
| E-mail: | investor@cgm.com |
| Internet: | www.cgm.com |
| ISIN: | DE000A288904 |
| WKN: | A28890 |
| Indices: | SDAX, TecDAX |
| Listed: | Regulated Market in Frankfurt (Prime Standard); Regulated Unofficial Market in Berlin, Dusseldorf, Hamburg, Munich, Stuttgart, Tradegate Exchange |
| EQS News ID: | 1958515 |
| End of Announcement | EQS News Service |
|
|
1958515 31-Jul-2024 CET/CEST
